Pediatric and Adolescent Unit, Department of Internal Medicine, University of Pavia, 27100, Pavia, Italy.
Pediatric Department, "V. Buzzi" Children's Hospital, 20154, Milan, Italy.
J Endocrinol Invest. 2023 Nov;46(11):2319-2325. doi: 10.1007/s40618-023-02086-4. Epub 2023 Apr 11.
Patients with Down Syndrome (DS) showed multiple comorbidities, including thyroid disorders, obesity, and metabolic derangement. Different thyroid hormone (THs) patterns and sensitivity to thyroid hormone indices (STHI) seem to be associated with metabolic disorders. The study's aim was to evaluate the prevalence of metabolic syndrome (MS) in pediatric patients affected by DS, taking into consideration the relationship between the metabolic parameters, THs and STHI.
We enlisted 50 euthyroid patients with DS (9.03 ± 4.46). Clinical parameters, TSH, FT3, FT4 and the presence of MS were recorded. Indexes of peripheral sensitivity (FT3/FT4 ratio) and central sensitivity (TSH index, TSHI; TSH T4 resistance index, TT4RI; TSH T3 resistance index, TT3RI) were also detected. Thirty healthy subjects were included as a control group.
MS was detected in 12% of the subjects with DS. FT3, FT4, and TSH levels were higher in DS than in the control group (p < 0.01); higher levels of FT3/FT4 ratio, TSHI and TT3RI and lower TT4RI values (p < 0.01) were also detected. A significant correlation was detected between FT3 and fasting blood glucose (FBG) (R = 0.46), triglyceride (TG) (r = 0.37), total (r = 0.55) and high density lipoprotein-cholesterol (HDL-C) (r = - 0.38), diastolic blood pressure (DBP) (r = - 0.4); FT3/FT4 ratio and waist circumference (WC) (r = 0.36); TSHI and total (r = 0.30) and HDL cholesterol (r = - 0.31); TT4RI and HDL cholesterol (r = - 0.31); TT3RI and total (r = 0.39) and HDL cholesterol (r = - 032).
We confirmed a higher MS prevalence in children with DS compared to the control group. A significant association between THs, STHI, and the glucose and lipid metabolism parameters was detected supporting their role in metabolic alterations related to the DS.
唐氏综合征(DS)患者存在多种合并症,包括甲状腺疾病、肥胖和代谢紊乱。不同的甲状腺激素(THs)模式和对甲状腺激素指数(STHI)的敏感性似乎与代谢紊乱有关。本研究的目的是评估患有 DS 的儿科患者中代谢综合征(MS)的患病率,同时考虑代谢参数、THs 和 STHI 之间的关系。
我们招募了 50 名甲状腺功能正常的 DS 患者(9.03±4.46 岁)。记录临床参数、TSH、FT3、FT4 和 MS 的存在情况。还检测了外周敏感性(FT3/FT4 比值)和中枢敏感性(TSH 指数、TSHI;TSH 与 T4 抵抗指数、TT4RI;TSH 与 T3 抵抗指数、TT3RI)指数。将 30 名健康受试者作为对照组纳入。
DS 组中 12%的患者出现 MS。DS 组的 FT3、FT4 和 TSH 水平高于对照组(p<0.01);还检测到更高的 FT3/FT4 比值、TSHI 和 TT3RI 值和更低的 TT4RI 值(p<0.01)。FT3 与空腹血糖(FBG)(R=0.46)、甘油三酯(TG)(r=0.37)、总胆固醇(r=0.55)和高密度脂蛋白胆固醇(HDL-C)(r=-0.38)、舒张压(DBP)(r=-0.4)之间存在显著相关性;FT3/FT4 比值与腰围(WC)(r=0.36);TSHI 与总胆固醇(r=0.30)和 HDL 胆固醇(r=-0.31);TT4RI 与 HDL 胆固醇(r=-0.31);TT3RI 与总胆固醇(r=0.39)和 HDL 胆固醇(r=-032)。
我们证实了 DS 患儿的 MS 患病率高于对照组。THs、STHI 与葡萄糖和脂质代谢参数之间存在显著相关性,支持它们在与 DS 相关的代谢改变中的作用。